NCT03684811 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03684811
Title	A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Forma Therapeutics, Inc.
Indications	liver carcinoma high grade glioma chondrosarcoma hepatocellular carcinoma Advanced Solid Tumor bile duct carcinoma biliary tract cancer intrahepatic cholangiocarcinoma
Therapies	Cisplatin + Gemcitabine + Olutasidenib Azacitidine + Olutasidenib Olutasidenib Nivolumab + Olutasidenib
Age Groups:	adult \| senior
Covered Countries	USA \| GBR \| FRA \| ESP \| AUS

NCT03684811
Clinical Trial Detail